Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 HPV testing and PAP test industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Million & Units)
2.1.2 Test type trends (USD Million & Units)
2.1.3 Technology trends (USD Million & Units)
2.1.4 End-use trends (USD Million & Units)
2.1.5 Regional trends (USD Million & Units)
Chapter 3 HPV Testing and PAP Test Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cervical cancer
3.2.1.2 Rising number of people suffering from human papillomavirus (HPV)
3.2.1.3 Growing awareness regarding cervical cancer screening among women
3.2.1.4 Surge in technological advancements regarding HPV and PAP test
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of reimbursement scenario
3.2.2.2 Stringent regulatory framework
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By technology
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Cancer screening progams globally
3.6 Technological landscape
3.7 Indsutry ecosystem analysis
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.8.3 Asia Pacific
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Competitive dashboard, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 HPV Testing and PAP Test Market, By Test Type
5.1 Key segment trends
5.2 Human papillomavirus (HPV) testing
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3 Papanicolaou (PAP) test
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.4 Co-testing
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 6 HPV Testing and PAP Test Market, By Technology
6.1 Key segment trends
6.2 Polymerase chain reaction (PCR)
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Market estimates and forecast, 2018 - 2032 (Units)
6.3 Liquid-based cytology
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Market estimates and forecast, 2018 - 2032 (Units)
6.4 Immunodiagnostics
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Market estimates and forecast, 2018 - 2032 (Units)
6.5 Hybrid capture
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5.2 Market estimates and forecast, 2018 - 2032 (Units)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 7 HPV Testing and PAP Test Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.2 Market estimates and forecast, 2018 - 2032 (Units)
7.3 Diagnostic centers
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.2 Market estimates and forecast, 2018 - 2032 (Units)
7.4 Others
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 8 HPV Testing and PAP Test Market Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Poland
8.3.8 Switzerland
8.3.9 The Netherlands
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.4.6 Thailand
8.4.7 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Becton Dickinson & Company
9.3 Quest Diagnostics
9.4 Roche Diagnostics
9.5 Hologic, Inc.
9.6 Onco Health Corporation
9.7 Femasys, Inc.
9.8 Qiagen N.V.
9.9 Seegene, Inc.
9.10 Arbor Vita Corporation
9.11 Mylab Discovery Solutions Pvt. Ltd.
